Stay updated on Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page.

Latest updates to the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page
- Check3 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a new deployment; the change is limited to metadata without visible content alterations.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, signaling a new page revision. This appears to be a metadata update rather than a change to core content or user-facing features.SummaryDifference0.0%

- Check39 days agoChange DetectedA new citation to the 2026 JAMA Dermatology article by Yosipovitch et al. was added; the prior 2025 online-ahead-of-print citation in Dermatol Ther (Heidelb) was removed.SummaryDifference0.0%

- Check46 days agoChange DetectedThe study’s Publications section now lists a newer/updated bibliographic version of the JAMA Dermatology LIBERTY-CSU CUPID phase 3 trial citation (with the final April issue details instead of the earlier online-ahead-of-print entry). The page header footer revision identifier was also updated (v3.5.3), reflecting a site update rather than study content.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check90 days agoChange DetectedRevision: v3.4.3 was added to the page, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page.